ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 236 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2019. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $15,257,390 | -69.2% | 1,454,470 | -61.4% | 0.04% | -74.3% |
| Q3 2023 | $49,479,984 | +100.5% | 3,765,600 | +92.3% | 0.14% | +97.3% |
| Q2 2023 | $24,678,851 | +12843.8% | 1,958,639 | +13306.2% | 0.07% | +7200.0% |
| Q1 2023 | $190,661 | -97.3% | 14,610 | -96.4% | 0.00% | -95.8% |
| Q4 2022 | $7,089,516 | -52.5% | 401,900 | -59.0% | 0.02% | -60.0% |
| Q3 2022 | $14,935,000 | -19.6% | 980,600 | -21.7% | 0.06% | -23.1% |
| Q2 2022 | $18,578,000 | +1308.5% | 1,252,700 | +832.1% | 0.08% | +1014.3% |
| Q4 2019 | $1,319,000 | +265.4% | 134,400 | +308.5% | 0.01% | +250.0% |
| Q3 2019 | $361,000 | -66.4% | 32,900 | -70.8% | 0.00% | -60.0% |
| Q1 2019 | $1,073,000 | -62.4% | 112,495 | -43.8% | 0.01% | -58.3% |
| Q3 2018 | $2,850,000 | -59.9% | 200,000 | -64.1% | 0.01% | -70.0% |
| Q2 2017 | $7,107,000 | +55.1% | 557,000 | +60.1% | 0.04% | +25.0% |
| Q3 2016 | $4,582,000 | -67.5% | 347,900 | -70.5% | 0.03% | -66.7% |
| Q1 2015 | $14,083,000 | – | 1,177,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 11,000,000 | $163,570,000 | 8.77% |
| Blue Harbour Group | 7,262,346 | $107,991,000 | 8.08% |
| RIVULET CAPITAL, LLC | 265,000 | $3,941,000 | 4.12% |
| Breithorn Capital Management | 336,760 | $5,008,000 | 2.92% |
| EMINENCE CAPITAL, LP | 7,791,132 | $115,854,000 | 2.56% |
| Chinook Capital Management | 76,275 | $1,134,000 | 1.73% |
| GARGOYLE INVESTMENT ADVISOR L.L.C. | 198,008 | $2,657,000 | 1.64% |
| Adirondack Research & Management Inc. | 190,749 | $2,836,000 | 1.63% |
| INTREPID CAPITAL MANAGEMENT INC /DE/ | 100,000 | $1,487,000 | 1.05% |
| PRICE MICHAEL F | 477,500 | $7,100,000 | 0.94% |